Background Left ventricular thrombus (LVT) is a well-recognised complication of acute
myocardial infarction (1), with warfarin being the mainstay treatment. Off-label use of direct …

Background: Literature on the preferred anticoagulant for treating left ventricular thrombus
(LVT) is lacking. Thus, our objective was to compare the efficacy of DOACs versus warfarin …

Background There is no clear consensus on the optimal choice of anticoagulant in patients
with left ventricular thrombi (LVT). Given the potentially fatal complications associated with …

Background: There are conflicting results regarding the safety and efficacy of direct oral
anticoagulants (DOACs) in the management of left ventricular thrombus (LVT) compared …

Background Left ventricular thrombus (LVT) is not uncommon and pose a risk of systemic
embolism, which can be mitigated by adequate anticoagulation. Direct oral anticoagulants …

Abstract Aims Direct oral anticoagulants (DOACs) are increasingly used off-label to treat
patients with left ventricular thrombus (LVT). We analyzed available meta-data comparing …

Introduction: This study aims to evaluate the efficacy and safety of direct oral anticoagulants
(DOACs) in the treatment of left ventricular thrombus (LVT). Warfarin has been shown to be …

Background Left ventricular thrombus (LVT) is a common occurrence in states that lead to
reduced left ventricular function with current management favoring vitamin K agonists (VKA) …

Patients with impaired left ventricular (LV) function can develop LV thrombus, a potentially
life‐threatening condition due to risk of stroke and embolization. Conventional treatment with …

Background Left ventricular thrombosis (LVT) is a well-recognized complication of ischemic
and non-ischemic heart disease. The incidence of this complication has drastically reduced …